Navigation Links
APIC Conference to Focus on Patient Safety and 'Targeting Zero' Initiatives to Reduce HAIs
Date:5/9/2008

Medical Errors Expert to Give Keynote Address

WASHINGTON, May 9 /PRNewswire-USNewswire/ -- More than 4,000 infection prevention and control professionals from around the world are expected to convene at a five-day conference next month to discuss many of the major issues facing their profession today.

Strategies for infection prevention, best practices, the changing legal landscape of healthcare-associated infections (HAIs) and emerging multidrug-resistant bacteria are among the topics that will be covered at the Association for Professionals in Infection Control and Epidemiology (APIC's) 35th Annual Educational Conference and International Meeting, June 15-19 in Denver, CO. The meeting is the largest annual gathering of infection prevention and control professionals from around the world.

Noted patient safety expert and author of Internal Bleeding: The Truth Behind America's Terrifying Epidemic of Medical Mistakes, Robert M. Wachter, MD, Professor and Associate Chairman of the Department of Medicine, University of California, San Francisco, will deliver APIC's keynote address. In his presentation, "What Can Infection Control and Patient Safety Learn from Each Other?" Wachter will reflect on the integration of infection prevention into patient safety and discuss how the field of infection prevention and control can teach vital lessons to individuals and organizations striving to decrease medical errors.

Also featured will be APIC's "Targeting Zero" campaign, a series of new educational initiatives promoting best practices and elimination strategies for Clostridium difficile-associated disease and infections that the Centers for Medicare & Medicaid Services (CMS) are planning for reduced reimbursement should these infections occur during a hospital stay. Results of a recent survey of APIC members on the "Pace of Progress" of adoption of interventions to prevent MRSA will also be presented.

Additional highlights of t
'/>"/>

SOURCE Association for Professionals in Infection Control andEpidemiology
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. AtriCure to Present at Thomas Weisel Partners 2007 Healthcare Conference
2. Matrixx Initiatives, Inc. to Present at the Roth Capital Partners 2007 New York Conference
3. BD to Present at the Bear Stearns 20th Annual Healthcare Conference
4. GPhAs 2007 Annual Policy Conference Features Top Generic Industry CEOs; FDA, Government Officials; Wall Street Analysts
5. ATS Medical to Present at the 2007 Thomas Weisel Partners Healthcare Conference
6. Omnicell to Present at Thomas Weisel Healthcare Conference 2007
7. AtriCure to Present at Roth Capital Partners 2007 New York Conference
8. Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference
9. MDS to Present at Thomas Weisel Partners Healthcare Conference
10. Hospira to Present at the Bear Stearns 20th Annual Healthcare Conference on September 11
11. AMICAS to Present at Thomas Weisel Partners Healthcare Conference 2007
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/12/2008)...ire-FirstCall/ -- (Nasdaq: WHRT, TSX:,WHT) World H...") announced,that the Toronto Stock Exchange ("TSX...g the eligibility for continued listing on the TSX... 709 and 710(a) of the TSX Company,Manual. This re...and,operating results, more specifically whether t...
(Date:5/12/2008)...rstCall/ -- Allied Healthcare Products,Inc. (Nasd... the third,quarter ending March 31 fell 64 percent...are, to about $100,000 in the current quarter, or ...creased by about $240,000 compared to the,third qu...and labor costs,this fiscal year eroded margins an...
(Date:5/12/2008)...Newswire-FirstCall/ -- China Yingxia,International... or "the,Company"), a leading provider in the nutr...ufacture and distribution of organic nutritional f...cts in the People,s Republic,of China ("PRC"), ann...iday, May 16, 2008, at 10:00 a.m. EDT, to discuss ...
(Date:5/12/2008)...RME TSX: COM, VANCOUVER, May 12 /PRNewswire-First... COM) today announced that it will report financia...ernoon of Tuesday, May 13,2008. Cardiome will hol...ern (1:30pm Pacific) on that day to discuss the re...l 416-641-6117 or,866-299-6655. There will be a se...
Breaking Medicine News(10 mins):Health News:WorldHeart Notified of TSX Delisting Review 2Health News:Allied Healthcare Net Falls on Manufacturing Delays 2Health News:Allied Healthcare Net Falls on Manufacturing Delays 3Health News:Allied Healthcare Net Falls on Manufacturing Delays 4Health News:Allied Healthcare Net Falls on Manufacturing Delays 5Health News:China Yingxia International, Inc. Announces Conference Call to Discuss First Quarter 2008 Results 2Health News:Cardiome To Release 2008 First Quarter Results 2Health News:Cardiome To Release 2008 First Quarter Results 3Health News:Cardiome To Release 2008 First Quarter Results 4
...that is used in hard plastics that are commonly us...g breast cancer,// according to a new study. Rese... of California report their findings in the recent...esearchers were able to prove that the chemical, b...
... only when they affect only the diseased organs or...esearchers attempted to direct microcapsules into ...elp of a laser impulse. They have succeeded in rel...l. They did this by putting the substance into a s...
...rtant information about how water reacts with the ... mutation that has eluded researchers for decades....n of the Journal of the American Chemical Society,...y have reported uncovering an important step in DN...
...f Health is using fines paid by speeding motorist ...er-one cause nationwide is motor vehicle// acciden...ed in 1998 uses these fines to fund research, and ...hester Medical Center are among the programs funde...
Other Medicine News:Health News:Microcapsules target cancer cells 2Health News:Microcapsules target cancer cells 3Health News:Elusive Step In DNA Mutation Uncovered By Researchers 2Health News:Elusive Step In DNA Mutation Uncovered By Researchers 3Health News:Elusive Step In DNA Mutation Uncovered By Researchers 4Health News:Fines Paid By Speeding Motorists Used in Funding Spinal Cord Injury Research 2
(Date:5/12/2008)... ATLANTA, May 12 /- Geo...nta- based HIV/AIDS vaccine development,company, a...ion common,stock purchase agreement with Fusion Ca...investor., The Company may sell up to $10 million...o time over a 25-month period after the Securities...
(Date:5/12/2008)... ANN ARBOR, Mich., May 12 /- Velc...mpletion of a first-in-man clinical trial for,its ...stigating as a,treatment for Rheumatoid Arthritis ...ical studies, VEL-0230 proved to be a powerful,ant...mation and inhibits,bone loss. Taken together, the...
(Date:5/12/2008)... Provides the Optimal Combination of Scaffoldi... Conformability, TEL AVIV, Israel, May 12 /PRNews...received CE Mark for its Presillion(TM) CoCr Coron...rtery lesions with a technologically,innovative fl...preserves the superb scaffolding the unprecedented...
(Date:5/12/2008)... Presentation of Phase 1 Clinical Data of MDX-1100... 2008, PRINCETON, N.J., May 12 /PRNewswi...nounced today that it has initiated the Phase 2 cl...man monoclonal antibody that,targets CXCL10 (also ...eumatoid arthritis (RA). MDX-1100 could potentiall...
Breaking Medicine Technology:GeoVax Secures $10 Million Financing Commitment 2GeoVax Secures $10 Million Financing Commitment 3Velcura Therapeutics, Inc. Reports Successful Phase 1 Clinical Trial of Novel Bone Disease Therapy 2Medinol Receives CE Mark for Presillion(TM) Cobalt Chromium Coronary Stent on Rx System, an Advanced Evolution of the NIR(R) Family of Stents 2Medarex Announces Initiation of Phase 2 Clinical Trials for the Treatment of Ulcerative Colitis and Rheumatoid Arthritis 2Medarex Announces Initiation of Phase 2 Clinical Trials for the Treatment of Ulcerative Colitis and Rheumatoid Arthritis 3Medarex Announces Initiation of Phase 2 Clinical Trials for the Treatment of Ulcerative Colitis and Rheumatoid Arthritis 4What are the causes and consequences of childhood obesity 3F 1889 1Story ideas from the Journal of Biological Chemistry 1885 1Study examines decision making deficits in older adults 9510 1Study examines decision making deficits in older adults 9510 2Study examines decision making deficits in older adults 9510 3Edwards Lifesciences Completes Sale of LifeStent Product Line to Bard 9507 1
...new standard in the field of hammertoe implants wi...ical grade silicone, these durable and lasting imp... flexibility while maintaining correct toe length ...stiffnesses. Lengths are determined by the surgeon...
...Nerve Electrodes provide direct cranial nerve moni... circumferential design provides sensitive contact...l-time recordings. This unique approach provides y... acoustic neuromas, microvascular decompressions, ...
State-of-the-art sleep recording and analysis
... offers the capability to acquire images in near-r...ess and Contrast levels, Auto-windowing, Image Man...e tube's Rhodium spectrum which is best adapted to...on flat panel digital detector, which is the resul...
Medicine Products: